RTI Surgical’s C-Plus™ PEEK Interbody Fusion system is now indicated for use with allograft, including the company’s proprietary map3® cellular allogeneic bone graft. This builds upon a previous indication for use solely with autograft.
Other 2016 regulatory announcements for RTI include:
RTI Surgical's C-Plus™ PEEK Interbody Fusion system is now indicated for use with allograft, including the company's proprietary map3® cellular allogeneic bone graft. This builds upon a previous indication for use solely with autograft.
Other 2016 regulatory announcements for RTI include:
RTI Surgical’s C-Plus™ PEEK Interbody Fusion system is now indicated for use with allograft, including the company’s proprietary map3® cellular allogeneic bone graft. This builds upon a previous indication for use solely with autograft.
Other 2016 regulatory announcements for RTI include:
Copy to clipboard 
